IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Authors
Keywords
-
Journal
Cell Reports
Volume 37, Issue 12, Pages 110126
Publisher
Elsevier BV
Online
2021-12-03
DOI
10.1016/j.celrep.2021.110126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
- (2021) Yojana Gokhale et al. BMC INFECTIOUS DISEASES
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- SARS-CoV-2 spike protein interacts with and activates TLR41
- (2021) Yingchi Zhao et al. CELL RESEARCH
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
- (2021) Walter Gottlieb Land GENES AND IMMUNITY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
- (2020) Ren-Di Jiang et al. CELL
- The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
- (2020) Tao Liu et al. EMBO Molecular Medicine
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
- (2020) Linnan Zhu et al. IMMUNITY
- The Dual Epidemics of COVID-19 and Influenza
- (2020) Lawrence O. Gostin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
- (2020) Sebastiano Cicco et al. MEDIATORS OF INFLAMMATION
- COVID-19 and flu, a perfect storm
- (2020) Edward A. Belongia et al. SCIENCE
- Immunological and inflammatory profiles in mild and severe cases of COVID-19
- (2020) Jin-Wen Song et al. Nature Communications
- Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis
- (2020) Rubina Mulchandani et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
- (2020) Maja Buszko et al. NATURE IMMUNOLOGY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Controlling Cytokine Storm Is Vital in COVID-19
- (2020) Lu Tang et al. Frontiers in Immunology
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- In vitro immunomodulatory activity of celastrol against influenza A virus infection
- (2018) Niloofar Khalili et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Oxymatrine Inhibits Influenza A Virus Replication and Inflammation via TLR4, p38 MAPK and NF-κB Pathways
- (2018) Jian-Ping Dai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
- (2018) Mira C. Patel et al. mBio
- Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer
- (2018) Anshu P. Gounder et al. PLoS Pathogens
- Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient
- (2018) Mickael Vourc’h et al. Frontiers in Immunology
- Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration
- (2018) Xuehong Jia et al. PLoS Pathogens
- Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways
- (2017) Jian-Ping Dai et al. MOLECULES
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury
- (2017) Zhikai Xiahou et al. Nature Communications
- DAMPs and influenza virus infection in ageing
- (2015) Ramar Perumal Samy et al. AGEING RESEARCH REVIEWS
- Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A Virus
- (2015) Yang Yu et al. JOURNAL OF VIROLOGY
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- (2013) Kari Ann Shirey et al. NATURE
- The complex link between influenza and severe sepsis
- (2013) Diana F Florescu et al. Virulence
- The inflammatory response in sepsis
- (2012) Markus Bosmann et al. TRENDS IN IMMUNOLOGY
- Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection
- (2012) Michael B.A. Oldstone et al. VIROLOGY
- Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses
- (2011) Kyoko Shinya et al. Virology Journal
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now